Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Nanosonics Limited ( (AU:NAN) ) has shared an update.
Nanosonics Limited has disclosed a change in director Sarah Butler’s relevant interest in the company, with Butler acquiring an indirect holding of 15,000 ordinary shares. The shares were purchased on market on 25 and 26 February 2026 via The Muskoka Trust, where Butler is both a director of the corporate trustee and a beneficiary, signalling initial equity alignment between the new director and shareholders.
The transaction, valued at about $50,977.60 at an average price of roughly $3.40 per share, marks Butler’s first recorded holding in Nanosonics. This move may be viewed positively by investors as it strengthens governance alignment and demonstrates personal financial commitment to the company’s future performance and strategic direction.
The most recent analyst rating on (AU:NAN) stock is a Buy with a A$3.50 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.
More about Nanosonics Limited
Nanosonics Limited is a medical technology company focused on infection prevention solutions for healthcare settings. Its primary products typically centre on automated disinfection systems designed to improve clinical safety and compliance in hospitals and other healthcare environments.
YTD Price Performance: -13.85%
Average Trading Volume: 457,956
Technical Sentiment Signal: Sell
Current Market Cap: A$1.04B
Learn more about NAN stock on TipRanks’ Stock Analysis page.